Skip to main content

Conference Correspondent

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

[widgetkit id="1" name="CC Event Nav"]
Effects of Blisibimod on Renal and Inflammation Biomarkers and on Serum Immunoglobulin and Infection Risk in Patients with Lupus: Results from the PEARL-SC and Open-Label Extension Studies
Read More
Safety and Efficacy of Epratuzumab in Patients with Lupus Confirmed in a Long-Term Open-Label Extension Study
Read More
Corticosteroid Use Reduced across 52 Weeks of Belimumab Therapy in Patients with Lupus: Combined Analyses from the BLISS Trials
Read More
Belimumab Shows Clinical Response and Sustained Reductions in Circulating B Cells and in IgG Levels in Patients with Lupus
Read More
Postmarketing Experience with Belimumab in Patients with Lupus in Clinical Practice Settings Confirms the Evidence from Clinical Trials
Read More
High Levels of Interferon Type I in Plasma of Patients with Lupus Predict Future Renal Disease
Read More
Biomarkers that Predict Development or Worsening of Lupus Nephritis in Patients with Systemic Lupus Erythematosus
Read More
Can MDHAQ/RAPID3 Be Used in Usual Care of Patients with Systemic Lupus Erythematosus?
Read More
Exploring a Novel Therapeutic Target in a Murine Model of Systemic Lupus Erythematosus: Targeting Sphingosine-1-Phosphate Receptors
Read More
Serious Infections among Patients with Lupus Who Receive Corticosteroids and Immunosuppressants
Read More
Page 24 of 25
Results 231 - 240 of 242